GE Healthcare, Incheon Free Economic Zone (IFEZ), and gene analysis technology company BRC, have announced a five-year plan to invest in the establishment of the “GE Global Ubiquitous Health Research and Development Center” (GE Global u-Health R&D Center). The facility will be used for research and development activities related to healthcare IT solutions. The Korean government and IFEZ see the establishment of the centre as an opportunity to gain advanced clinical knowledge, build professional skills and create jobs through healthcare IT, which is a mainstream green industry. Also, the facilitation of convergence between healthcare technologies and related industries will contribute to the advancement of the domestic IT industry. In 2007, GE Healthcare established its first Asia EHR (electronic health records) R&D Center in Korea. It is envisioned that its skilled researchers, clinical expertise and technology will become a part of the research and operation of the GE Global u-Health R&D Center. Be a part of Elets Collaborative Initiatives. Join Us for
Upcoming Events and explore business opportunities. Like us on
Facebook , connect with us on
LinkedIn and follow us on
Twitter ,
Instagram. "Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here! 
Related Corporate Updates
Rajendra Kshirsagar Named CIO of Hyderabad's Star Hospitals
Rajendra Kshirsagar has been appointed Chief Information Officer (CIO) of Star Hospitals, the Hyderabad-based multispeci...
Mulk Technology Partners with OnClarity USA to Launch AI-Powered Digital Healthcare Platform
The integrated platform combines hospital management, AI-driven revenue cycle management and patient engagement tools, t...
Paras Healthcare’s ₹7,500 Crore IPO Valuation Puts Hospital Network Expansion in Focus
With eight hospitals and 2,211 beds across northern and eastern India, Paras Healthcare’s public issue comes as the co...
Even Healthcare Raises $50 Million as Investors Bet on an Integrated Care Model
Bengaluru-based healthcare startup’s $50 million Series B funding highlights investor appetite for integrated care mod...
Mankind Pharma Appoints Anish Vanraj Bafna as Independent Director
Mankind Pharma Limited has appointed Anish Vanraj Bafna as an Independent Director on its Board, bringing more than thre...
Shilpi Sinha Takes Charge as Director, Country Head – GCO India at Johnson & Johnson Innovative Medicine
Shilpi Sinha has taken charge as Director, Country Head – GCO India at Johnson & Johnson Innovative Medicine, brin...
Apollo Hospitals Appoints Abhishek Jain as Senior General Manager
Apollo Hospitals has appointed Abhishek Jain as Senior General Manager, strengthening its leadership team with a profess...
Sandoz India Appoints Priyaranjan Jha as Global Head of GCCs and Country President
Sandoz India has appointed Priyaranjan Jha as Global Head of Global Capability Centres (GCCs) and Country President, San...
Apollo Hospitals Appoints Upasana Kamineni Konidela as Director – Projects Amid ₹8,600-Crore Expansion
Apollo Hospitals has appointed Upasana Kamineni Konidela as Director – Projects, assigning her a key role in the plann...
MedVital Secures ₹18 Cr Funding to Expand Advanced Wound Care and Regenerative Aesthetics Portfolio
India’s medtech ecosystem continues to witness growing investor interest in clinically driven healthcare innovation, w...